1706 studies found for:    Open Studies | "Breast Diseases"
Show Display Options
Rank Status Study
21 Unknown  Women At Risk: The High Risk Breast Cancer Program
Condition: Breast Cancer
22 Recruiting Randomized Study of Hypofractionated and Conventional Fractionation Radiotherapy After Breast Conservative Surgery
Condition: Breast Cancer
Intervention: Radiation: radiotherapy
23 Not yet recruiting Preventing Seroma Formation After Axillary Lymph Node Dissection for Breast Cancer by Early Vacuum Assisted Closure
Condition: Breast Neoplasms
Interventions: Procedure: vacuum assisted closure in experimental arm;   Procedure: Axillary dissection
24 Unknown  Irinotecan/Capecitabine Versus Capecitabine in Patients Treated With A/T for HER2 Negative Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Intervention: Drug: Irinotecan, Capecitabine
25 Unknown  Breath Testing for Breast and Colon Cancer Diagnosis- NaNose Study
Conditions: Breast Cancer;   Colon Cancer
26 Recruiting Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Carboplatin and Paclitaxel;   Drug: Doxorubicin, cyclophosphamide;   Drug: Doxorubicin, cyclophosphamide, carboplatin, thiotepa, cyclophosphamide
27 Unknown  An Effective and Compliance Regimen of Paclitaxel Plus Cisplatin to Treat Metastatic Breast Cancer
Condition: Breast Neoplasms
Intervention: Drug: PhyxolTM, Cisplatin
28 Not yet recruiting Eribulin Mesylate and Everolimus in Treating Patients With Triple-Negative Metastatic Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer;   HER2-negative Breast Cancer;   Progesterone Receptor-negative Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer;   Triple-negative Breast Cancer
Interventions: Drug: everolimus;   Drug: eribulin mesylate;   Other: pharmacological study;   Other: laboratory biomarker analysis
29 Unknown  Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Cancer
Condition: Triple Negative Breast Cancer
Interventions: Drug: Paclitaxel plus carboplatin;   Drug: Paclitaxel and epirubicin
30 Recruiting A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: Trastuzumab;   Drug: Paclitaxel;   Drug: Lapatinib
31 Recruiting CLI Specimen Analyser for Ex-vivo Assessment of Margin and Lymph Node Status in Breast Cancer Surgical Specimens
Condition: Breast Cancer
32 Recruiting Phase 1b Study of PD-0332991 in Combination With T-DM1(Trastuzumab-DM1)
Condition: Advanced Breast Cancer
Intervention: Drug: PD-0332991 and T-DM1
33 Recruiting Diagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer
Conditions: Recurrent Breast Cancer;   Stage IV Breast Cancer
Intervention: Drug: [18F]fluoroestradiol (FES)
34 Recruiting Preoperative Clinical Trial of Sorafenib in Combination With Cisplatin Followed by Paclitaxel for Triple Negative (ER-, PR-, Her2-)Early Stage Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Sorafenib
35 Unknown  A Clinical Trial to Study the Effects of Nanoparticle Based Paclitaxel Drug, Which Does Not Contain the Solvent Cremophor, in Advanced Breast Cancer
Condition: Advanced Breast Cancer
Intervention: Drug: Nanoxel (Paclitaxel Nanoparticle formulation )
36 Recruiting AKT Inhibitor in Oestrogen Positive Breast Cancer
Condition: Invasive Breast Cancer
Intervention: Drug: AZD5363
37 Recruiting A Study Of PF-06263507 In Patients With Advanced Solid Tumors
Conditions: Neoplasms;   Carcinoma, Non Small Cell Lung;   Breast Neoplasms;   Ovarian Neoplasms
Intervention: Drug: PF-06263507
38 Recruiting Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
Conditions: Invasive Ductal Carcinoma;   Ductal Carcinoma in Situ
Intervention: Radiation: Intra-operative Radiation Therapy - IORT
39 Recruiting Study of Vitamin D Supplementation Tailored to Vitamin D Deficiency in Breast Cancer Patients
Condition: Breast Cancer
Intervention: Drug: calcium and cholecalciferol
40 Recruiting Intraoperative Imagery of Breast Cancer With Folate-FITC (EC17)
Condition: Resectable Breast Cancer
Intervention: Drug: EC17

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years